Figure 9.

Immunoblots of PANC-1 and MiaPaCa-2 cells show degradation of the target Sirt1 upon cambinol treatment.

Stenzinger et al. BMC Cancer 2013 13:450   doi:10.1186/1471-2407-13-450
Download authors' original image